Cancidas OverviewCaspofungin (INN) (brand name Cancidas) is a lipopeptide antifungal drug from Merck & Co., Inc. discovered by James Balkovec, Regina Black and Frances A. Bouffard. It is a member of a new class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall. Caspofungin was the first inhibitor of fungal (1→3)-β-D-...
Read more Cancidas Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Caspofungin
Recent Cancidas Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 50mg, 50mg/vial, 70mg, 70mg/vial
- Powder: 50mg/vial, 70mg/vial
NDC Database Records for Cancidas: (2 results)Sorted by National Drug Code
- 0006-3822 Cancidas 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Merck Sharp & Dohme Corp.
- 0006-3823 Cancidas 7 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Merck Sharp & Dohme Corp.